It is estimated that in Italy around 1,000 people under the age of 35 die every year from sudden cardiac death (SCD). This is a rare but extremely fearful condition in which a healthy heart for most people can suddenly stop beating due to arrhythmias or structural problems. It can affect teenagers, young adults, athletes and even people without previous symptoms.
“Arrhythmia risk and cardiomyopathies. From diagnosis to prevention of sudden cardiac death” will be discussed on 16, 17 and 18 October in Messina, during a Congress that will take place in the main hall of the University, in Piazza Pugliatti.
An important event in the national cardiology panorama that brings together experts, researchers and clinicians to discuss the main scientific acquisitions, emerging guidelines and strategies for the prevention and treatment of sudden cardiac death. The event, whose scientific director is prof. Gianluca di Bella of the Department of Clinical and Experimental Medicine of the University of Messina, director of UOC cardiology of UTIC and head of the regional Reference Center on Rare Cardiac Diseases, is carried out in collaboration with the Rare Diseases Desk of the University Hospital and will be developed in eleven sessions. In addition to the diagnosis of the main cardiomyopathies, the clinical management as well as the identification of predictors of sudden cardiac death will be covered. It will thus be possible to promote the exchange of knowledge between the laboratory, white coat and health policies, to improve the early identification of patients at risk and optimize care in hospital and community contexts. The event aims to connect scientific research, clinical practice and community involvement, with particular attention to the needs of patients suffering from cardiomyopathies.
The inauguration will see the participation, in a round table, of civil society and associations of patients suffering from cardiomyopathies, to promote greater awareness and greater involvement on the topic. Direct testimonies, multidisciplinary care perspectives and family support initiatives will be presented.
The three days is aimed at:
– General practitioners, cardiologists, cardiac surgeons, clinical geneticists, radiologists, movement therapists and healthcare personnel involved in the management of cardiomyopathies.
– Patients, family members and patient associations interested in receiving updated information, support tools and opportunities for active involvement.
– Researchers and students interested in the topics of arrhythmia, cardiomyopathies and prevention of sudden cardiac death.